Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration-resistant Prostrate Cancer”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Large-scale testing (Phase 3)Study completedNCT03016312

What this trial is testing

Atezolizumab (Anti-PD-L1 Antibody) in Combination With Enzalutamide in Participants With Metastatic Castration-Resistant Prostrate Cancer (mCRPC) After Failure of an Androgen Synthesis Inhibitor And Failure of, Ineligibility For, or Refusal of a Taxane Regimen

Who this might be right for

Prostatic Neoplasms, Castration-Resistant

Hoffmann-La Roche 759

Early research (Phase 1)Study completedNCT00730639

What this trial is testing

Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies

Who this might be right for

Metastatic Castration-resistant Prostrate CancerRenal Cell CarcinomaMetastatic Melanoma+1 more

Bristol-Myers Squibb 395

Testing effectiveness (Phase 2)WithdrawnNCT01750866

What this trial is testing

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Who this might be right for

Castrate-resistant Metastatic Prostate Cancer

Case Comprehensive Cancer Center

Large-scale testing (Phase 3)Looking for participantsNCT06629779

What this trial is testing

Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.

Who this might be right for

Metastatic Castration-Resistant Prostate Cancer